The Valley Desk

Publications from Bristol Myers Squibb, page 2

A filtered view. Show the full list.

Refine

280 publications · listings 25–48

Listings

  1. ArticleNature

    Identification of an allosteric site on the E3 ligase adapter cereblon

    Verified Author affiliations on the Europe PMC record name Bristol Myers Squibb, GSK. Affiliation source

    Biomedical and life sciencesAdded

  2. ReviewNPJ digital medicine

    Machine learning models for drug-drug interaction prediction from computational discovery to clinical application

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Biomedical and life sciencesAdded

  3. Clinical trial reportThe New England journal of medicine

    Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Clinical careAdded

  4. ArticleCurrent medical research and opinion

    Plain language summary looking at the impact of increased patient out-of-pocket costs on stopping oral anticoagulant treatment among Medicare beneficiaries with atrial fibrillation treated with apixaban

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Public healthAdded

  5. ArticleCurrent medical research and opinion

    Cost comparison between apixaban and low molecular weight heparin (LMWH) among venous thromboembolism (VTE) patients with cancer

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Clinical careAdded

  6. ArticlePersonalized medicine

    Toward a harmonized assessment of MRD by NGS: blinded pilot study of NGS assays by MPAACT consortium

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Clinical careAdded

  7. ArticleBioanalysis

    2025 White Paper on Recent Issues in Bioanalysis: Redosing Patients with AAV Gene Therapy; CRS Immunogenicity Risk; Shedding Assays; NHP Studies Immunogenicity; CMC vs Bioanalytical Assays; Artificial Intelligence-Powered Genomic Pipelines for NGS (PART 3A - Recommendations on Gene, Cell, and Vaccine Therapies Immunogenicity & Technologies; Biotherapeutics & Biosimilars Immunogenicity Assessment & Clinical Relevance PART 3B - Regulatory Agencies' Input on Immunogenicity/Technologies of Biotherapeutics, Gene, Cell & Vaccine Therapies)

    Verified Author affiliations on the Europe PMC record name Bristol Myers Squibb, GSK. Affiliation source

    Biomedical and life sciencesAdded

  8. ArticleBioanalysis

    2025 White Paper on Recent Issues in Bioanalysis: Biomarkers Calibrators & Stability; Evaluation of NULISA; Neurofilament & Autoantibody Biomarker Assays; Removing IgM Interference; ELISpot & FluoroSpot Best Practices; Modular HD Cytometry; Single-cell Analysis Imaging Cytometry (PART 2A - Recommendations on Biomarkers Discovery, Development, Validation & Regulatory Approval, Ligand-Binding Assays (LBA) and Cell-Based Assays (CBA) PART 2B - Regulatory Agencies' Input on Biomarkers, IVD/CDx and Biomarker Assay Validation (BAV))

    Verified Author affiliations on the Europe PMC record name Bristol Myers Squibb, GSK, Johnson & Johnson. Affiliation source

    Biomedical and life sciencesAdded

  9. ArticleBiometrics

    TITE-safety: a robust time-to-event safety monitoring approach for clinical trials

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Clinical careAdded

  10. ArticleInternational journal of surgery (London, England)

    Decoding hepatocellular carcinoma prognosis: a machine learning-derived methylation signature integrating transcriptomic and tumor microenvironment insights

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Disease researchAdded

  11. ArticleBMJ oncology

    Efficacy of nivolumab plus relatlimab versus BRAF/MEK inhibitors for first-line treatment of BRAF-mutant advanced melanoma: A matching-adjusted indirect comparison

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Clinical careAdded

  12. Clinical trial reportJournal for immunotherapy of cancer

    Phase 1b/2 study of BMS-813160, a CCR2/5 dual antagonist, in combination with chemotherapy or nivolumab in patients with advanced pancreatic or colorectal cancer

    Verified Author affiliations on the Europe PMC record name Bristol Myers Squibb, Thomas Jefferson University. Affiliation source

    Clinical careAdded

  13. ArticleCancer immunology research

    The Presence of CD11c+ B Cells with Potent Effector Memory Phenotype in Lung Adenocarcinoma Correlates with Overall Patient Survival

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Disease researchAdded

  14. ArticleCirculation. Heart failure

    Dephospho-Uncarboxylated Matrix Gla-Protein Is Associated With Adverse Outcomes in Heart Failure

    Verified Author affiliations on the Europe PMC record name Bristol Myers Squibb, Hospital of the University of Pennsylvania, with Penn Medicine linked by the institution reference. Affiliation source

    Disease researchAdded

  15. Clinical trial reportJournal of the American Heart Association

    Ex Vivo Effect of Apixaban on Hemostatic Biomarkers in Children With Heart Disease: A SAXOPHONE Trial Substudy

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Disease researchAdded

  16. ArticleJournal of the American Heart Association

    Clinical Impact of Switching From or Persisting With Rivaroxaban or Apixaban After a Bleeding Event: A Real-World Study in Patients With Nonvalvular Atrial Fibrillation

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Clinical careAdded

  17. ArticleThe American journal of sports medicine

    Comparing 10-Year Follow-up Outcomes Among Patients Without Unstable Chondral Lesions Versus Those With Unstable Chondral Lesions (Left In Situ) at the Time of Arthroscopic Partial Meniscectomy

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Clinical careAdded

  18. ArticleJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

    Impact of social determinants of health on treatment patterns and outcomes in metastatic non-small cell lung cancer

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Public healthAdded

  19. ArticleJCO precision oncology

    Generic Protocols for the Analytical Validation of Next-Generation Sequencing-Based Circulating Tumor DNA Assays, Version 2.0

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Biomedical and life sciencesAdded

  20. ReviewThe AAPS journal

    HLA Class II Alleles DRB1*11:01 and DQB1*03:01 Unmask Immunogenetic Susceptibility to Anti-Nivolumab Antibodies in Combination with Ipilimumab

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Disease researchAdded

  21. ArticleThe AAPS journal

    Updated Recommendations for the Bioanalysis of Antibody-Drug Conjugates (ADC) from the ADC working group of the AAPS Bioanalytical Community

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Biomedical and life sciencesAdded

  22. ArticleJournal of comparative effectiveness research

    Development and validation of a method to compare outcomes between switchers and continuers in routine clinical practice

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Clinical careAdded

  23. Clinical trial reportJAMA cardiology

    Effects of Mavacamten on Measures of Cardiopulmonary Exercise Testing Beyond Peak Oxygen Consumption: A Secondary Analysis of the EXPLORER-HCM Randomized Trial

    Verified Author affiliations on the Europe PMC record name Bristol Myers Squibb, Perelman School of Medicine, University of Pennsylvania. Affiliation source

    Clinical careAdded

  24. Clinical trial reportJAMA dermatology

    Meaningful Change Thresholds for the Psoriasis Symptoms and Signs Diary: A Secondary Analysis of a Randomized Clinical Trial

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Clinical careAdded